Melissa Layman
Chief Commercial Officer, Flexion Therapeutics.
Companies
- Flexion TherapeuticsChief Commercial Officer Mar 13, 2020 to Nov 19, 20211
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Flexion Therapeutics0 shares2Nov 19, 2021
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 19, 2021Returned to company 103,956 shares at $8.50 of Flexion Therapeutics2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2